The third “KoviVak” coronavirus vaccine developed by the Chumakov Center has been registered in Russia.
The registration of the drug on Saturday was announced by Prime Minister Mikhail Mishustin. The vaccine was the third registered in Russia.
The first 120 thousand doses of the KoviVak vaccine will be launched into civil circulation in mid-March, Mishustin noted.
The developer also plans to enter international markets.
It is noted that the drug is based on inactivated virus.
Photo: from open sources